Goran Ando - Feb 9, 2022 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Stock symbol
EYPT
Transactions as of
Feb 9, 2022
Transactions value $
$0
Form type
4
Date filed
2/11/2022, 03:48 PM
Previous filing
Jan 5, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Options Exercise $0 +2.75K +127.91% $0.00 4.9K Feb 9, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Award $0 +3.25K $0.00 3.25K Feb 9, 2022 Common Stock 3.25K $0.00 Direct F1
transaction EYPT Restricted Stock Units Options Exercise $0 -2.75K -100% $0.00* 0 Feb 9, 2022 Common Stock 2.75K $0.00 Direct F2
transaction EYPT Stock Option (Right to Buy) Award $0 +12K $0.00 12K Feb 9, 2022 Common Stock 12K $10.13 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Will fully vest on the one-year anniversary of the grant date.
F2 Fully vested on the one-year anniversary of the grant date.